Articles:

Symposium: Use of Imaging in Drug R&D. Bethesda, Maryland, USA. September 11-13, 1998. Proceedings and abstracts
J Clin Pharmacol 1999 39: S4 -S60. [PDF]  

IR Wilding and DL Heald

Visualization of product performance in the gut: what role in the drug development/regulatory paradigm?
J Clin Pharmacol 1999 39: S6 -S9. [PDF]  

DE Salazar and AJ Fischman

Central nervous system pharmacokinetics of psychiatric drugs
J Clin Pharmacol 1999 39: S10 -S12. [PDF]  

JS Fowler, ND Volkow, YS Ding, GJ Wang, S Dewey, MW Fischman, R Foltin, and R Hitzemann

Positron emission tomography studies of dopamine-enhancing drugs
J Clin Pharmacol 1999 39: S13 -S16. [Abstract] [PDF]  

SJ Offord, DF Wong, and S Nyberg

The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action
J Clin Pharmacol 1999 39: S17 -S24. [Abstract] [PDF]  

MS Berridge and DL Heald

In vivo characterization of inhaled pharmaceuticals using quantitative positron emission tomography
J Clin Pharmacol 1999 39: S25 -S29. [PDF]  

D Piwnica-Worms and M Marmion

Characterization of drug specificity by pharmacokinetic analysis in gene knockout mice
J Clin Pharmacol 1999 39: S30 -S33. [PDF]  

M Sadelain and RG Blasberg

Imaging transgene expression for gene therapy
J Clin Pharmacol 1999 39: S34 -S39. [PDF]  

AF Shields, PT Ho, and Grierson, JR

The role of imaging in the development of oncologic agents
J Clin Pharmacol 1999 39: S40 -S44. [PDF]  

ME Schmidt

The future of imaging in drug discovery
J Clin Pharmacol 1999 39: S45 -S50. [PDF]  

R Frank

Nuclear bioimaging in drug development and regulatory review
J Clin Pharmacol 1999 39: S51 -S55. [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.